These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 1777606

  • 21. Non-Hodgkin's lymphoma presenting as an endobronchial tumor: report of eight cases and literature review.
    Solomonov A, Zuckerman T, Goralnik L, Ben-Arieh Y, Rowe JM, Yigla M.
    Am J Hematol; 2008 May; 83(5):416-9. PubMed ID: 18175356
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 25. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
    Ab Hamid S, Wastie ML.
    Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
    Hou M, Li L, Qiu M, Yan X, Zhu J, Gou HF.
    Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070
    [Abstract] [Full Text] [Related]

  • 28. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
    López-Guillermo A, García-Conde J, Alvarez-Carmona AM, León P, Maldonado J, Alcalá A, Zubizarreta A, Sancho-Tello R, Carbonell F, Contreras E, Besses C, Hernando A, Fontanillas M, Montserrat E.
    Med Clin (Barc); 1998 May 09; 110(16):601-4. PubMed ID: 9656196
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ, Zhang QY, Chen DF, Guan XJ, Zhang BL, Ma J.
    Ai Zheng; 2005 Dec 09; 24(12):1498-502. PubMed ID: 16351800
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM.
    Ann Rheum Dis; 2006 Aug 09; 65(8):1033-7. PubMed ID: 16322082
    [Abstract] [Full Text] [Related]

  • 35. Primary non-Hodgkin's lymphoma of the common bile duct.
    Maymind M, Mergelas JE, Seibert DG, Hostetter RB, Chang WW.
    Am J Gastroenterol; 1997 Sep 09; 92(9):1543-6. PubMed ID: 9317083
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
    Osorio S, Bernis C, de La Cámara R.
    Haematologica; 2002 Feb 09; 87(2):ELT05. PubMed ID: 11836182
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.